Search Results

Now available is a 30-minute eCourse for members of the multidisciplinary cancer care team on how to use consistent, evidence-based health literacy best practices as it relates to lung cancer biomarker testing. Complete “Health Literacy Best Practices for Lung Cancer Biomarkers” to gain a lexicon of health terminology that resonates with patients and their caregivers and access downloadable resources …

Hear patient advocacy professionals discuss the impact of using patient-centered vocabulary during precision medicine conversations.

This webinar will highlight how community cancer programs are using a new approach to optimize biomarker testing processes through the addition of a precision medicine steward. Precision medicine experts will outline strategies and key metrics that demonstrate how precision medicine stewardship can improve coordination and streamline workflows to ensure timely, equitable testing for patients who may …

If you are a physician, advanced practice provider, pharmacist, nurse, or other healthcare professional involved in treating patients with cancer immunotherapies, please join the Association of Community Cancer Centers and Boston University for complimentary tele-mentoring sessions on the optimal management of Immune-related Adverse Events (irAEs). Each month we will cover a different topic, allowing …

This webinar will review how the steps in the life cycle of a patient specimen can affect its molecular integrity and molecular analysis results. Our expert speaker will define the roles of stewardship across the specimen chain of custody, discuss common factors that compromise specimen fitness for molecular testing, and describe solutions to improve preanalytics and tissue stewardship.

Two thought leaders who have deep knowledge of—and experience in—biomarker testing in patients with hematologic malignancies will discuss best practices for biomarker testing in chronic lymphocytic leukemia (CLL) and multiple myeloma based on patient case discussions and the latest guidelines.

Learn about open opportunities to participate in an ACCC-supported QI project, then see how ACCC's online self-assessment tools can help identify areas of improvement at your program or practice.

Key issues in high integrity tissue acquisition facing community cancer programs. (December 17, 2020)

Gain important and practical information for the assessment of measurable residual disease as part of routine clinical practice for patients with chronic lymphocytic leukemia (CLL).

Genetic Testing and Implementation of Cancer Genomics in Clinical Care was part of the Oncology State Societies at ACCC Virtual Symposium on Friday, November 13, 2020.

Take a deeper dive into the differences between germline and somatic mutations and what this means for patients with cancer and their families. Considerations for tumor types where somatic and germline testing comes into play for colorectal, ovarian, pancreatic, and prostate cancers will be discussed.

This on-demand panel discussion provides a review pf the current policies and regulations that drive costs related to biomarker testing.

This on-demand webinar will explore the differences between germline and somatic mutations (with case examples), review AMP/ASCO/CAP guidelines, give somatic testing examples, and share findings from a LUNGevity/FORCE patient survey.

Gain an introduction to cancer biomarkers and its relevant terminology, review different types of biomarkers, discuss the current landscape of biomarker-driven therapies by tumor type, and implications for cancer care delivery.

An insightful and thought-provoking discussion about the expanding role and importance of early engagement of pathologists—the laboratory physicians who guide, develop, and implement biomarker testing.